Mylan Introduces Symfi(TM) Triple Combo Once-Daily HIV Treatment in the U.S.

Approval complements growing portfolio of cost-saving antiretroviral medications available to patients in the U.S., including recently announced Symfi Lo™ and Cimduo™ All ARV regimens are being offered at a significant discount to the price of competing... Biopharmaceuticals, HIV/AIDS, FDA, Product Launch Mylan, Symfi, efavirenz, lamivudine, tenofovir
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news